The FDA might be preparing to OK a second round of COVID-19 booster shots that target the original virus as well as the Omicron variant to protect people over 65 and others who are particularly vulnerable.
, which published an article Monday citing unnamed sources familiar with discussions.
“The officials are moving toward authorizing the second jabs of the Omicron-targeted shots for people who are 65 years and older or who have weakened immune systems, though the officials haven’t reached a final decision and could change their mind, one of the people said,”The FDA approved using the so-called bivalent booster in August. The CDC granted approval in September, but a second round of approval would be needed.
The FDA has said that might be needed. But some health officials say there isn’t enough evidence showing that a six-month booster is effective. Canada and the United Kingdom plan to offer spring boosters to people at highest risk of severe COVID-19 illness. But U.S. officials have said they want an annual vaccination schedule, “partly because many people have tired of frequent boostings,”Lack of FDA progress is frustrating “a small but determined group of people who are keen not to have to wait until the autumn to get another dose of COVID vaccine,”
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
U.S. FDA to soon decide on second round of Omicron-tailored boosters - WSJThe U.S. Food and Drug Administration is close to making a decision on authorization of a second dose of updated COVID-19 vaccine boosters for high-risk people, the Wall Street Journal reported on Tuesday, citing sources.
Baca lebih lajut »
FDA close to a decision on whether to authorize a second round of updated omicron-targeting COVID booster: WSJThe Food and Drug Administration is getting close to a decision on whether to authorize a second round of the updated booster that targets omicron — the...
Baca lebih lajut »
FDA looks into dental device After KHN-CBS investigationThe FDA’s interest in the AGGA dental device follows a KHN-CBS News investigation, according to a former agency official.
Baca lebih lajut »
WSJ News Exclusive | GOP Lawmakers Launch Probe Into FDA’s Handling of Baby-Formula ShortageHouse Republicans are ramping up their scrutiny of the U.S. Food and Drug Administration and the White House’s handling of last year’s nationwide baby formula shortage.
Baca lebih lajut »
House Republicans open investigation into Biden FDA's response to baby formula shortageHouse Oversight Committee Chairman James Comer opened an investigation into President Biden's FDA's response to the 2021 baby formula shortage on Tuesday.
Baca lebih lajut »